Christopher Henney
2009
In 2009, Christopher Henney earned a total compensation of $56.5K as Acting principal executive officer; Chairman of the Board of Directors at Oncothyreon.
Compensation breakdown
Stock Awards | $56,513 |
---|---|
Total | $56,513 |
Henney received $56.5K in stock awards, accounting for 100% of the total pay in 2009.
Rankings
In 2009, Christopher Henney's compensation ranked 9,803rd out of 9,885 executives tracked by ExecPay.
Classification | Ranking | Percentile |
---|---|---|
All | 9,803 out of 9,885 | 1st |
Division Services | 1,448 out of 1,466 | 1st |
Major group Engineering, Accounting, Research, Management, And Related Services | 165 out of 167 | 1st |
Industry group Research, Development, And Testing Services | 44 out of 44 | 0th |
Industry Commercial Physical and Biological Research | 41 out of 41 | 0th |
Source: SEC filing on April 24, 2012.
Henney's colleagues
We found five more compensation records of executives who worked with Christopher Henney at Oncothyreon in 2009.
2009
Robert Kirkman
Oncothyreon
Chief Executive Officer
2009
Gary Christianson
Oncothyreon
Chief Operating Officer
2009
Diana Hausman
Oncothyreon
Vice President, Clinical Development
2009
Shashi Karan
Oncothyreon
Secretary
2009
Scott Peterson
Oncothyreon